Application of oestrogen receptor ligand binding domain to the generic isolation of oestrogens by receptor affinity chromatography
Byford, M.F.; Sauer, M.J.
Chromatographia 59(Supp): S123-S130
2004
ISSN/ISBN: 0009-5893
DOI: 10.1365/s10337-003-0246-4
Accession: 004045677
Human oestrogen receptor (alpha) ligand binding domain (hER-LBD) was expressed in E. coli and isolated using a novel approach. The solubilized recombinant receptor had the expected biological activity in terms of ligand binding affinity and selectivity, indicating the potential for use in the proposed receptor affinity chromatography (RAC) application.
PDF emailed within 0-6 h: $19.90
Related References
Calleri, E.; Fracchiolla, G.; Montanari, R.; Pochetti, G.; Lavecchia, A.; Loiodice, F.; Laghezza, A.; Piemontese, L.; Massolini, G.; Temporini, C. 2012: Frontal affinity chromatography with MS detection of the ligand binding domain of PPARγ receptor: ligand affinity screening and stereoselective ligand-macromolecule interaction Journal of Chromatography. a 1232: 84-92Jacobs, M.N.; Dickins, M.; Lewis, D.F.V. 2003: Homology modelling of the nuclear receptors: human oestrogen receptorbeta (hERbeta), the human pregnane-X-receptor (PXR), the Ah receptor (AhR) and the constitutive androstane receptor (CAR) ligand binding domains from the human oestrogen receptor alpha (hERalpha) crystal structure, and the human peroxisome proliferator activated receptor alpha (PPARalpha) ligand binding domain from the human PPARgamma crystal structure Journal of Steroid Biochemistry and Molecular Biology 84(2-3): 117-132
Jacobs, M.N.; Dickins, M.; Lewis, D.F.V. 2003: Homology modelling of the nuclear receptors Human oestrogen receptorbeta , the human pregnane-X-receptor , the Ah receptor and the constitutive androstane receptor ligand binding domains from the human oestrogen receptor alpha crystal structure, and the human peroxisome proliferator activated receptor alpha ligand binding domain from the human PPARgamma crystal structure Journal of Steroid Biochemistry and Molecular Biology 84(2-3): 117-132
Jacobs, M.N.; Lewis, D.F.V. 2000: Homology modelling of the oestrogen receptor beta ligand binding domain from the human oestrogen receptor alpha crystal structure Toxicology Letters (Shannon) 116(Suppl 1): 58-59, September 1st
Behrendt, N.; Ronne, E.; Dano, K. 1996: Domain interplay in the urokinase receptor. Requirement for the third domain in high affinity ligand binding and demonstration of ligand contact sites in distinct receptor domains Journal of Biological Chemistry 271(37): 22885-22894
Backlund, M.; Ingelman-Sundberg, M. 2004: Different structural requirements of the ligand binding domain of the aryl hydrocarbon receptor for high- and low-affinity ligand binding and receptor activation Molecular Pharmacology 65(2): 416-425
Lim, J.P.L.; Braza, M.K.E.; Nellas, R.B. 2021: The effect of ligand affinity to the contact dynamics of the ligand binding domain of thyroid hormone receptor - retinoid X receptor Journal of Molecular Graphics and Modelling 104: 107829
Akamizu, T.; Inoue, D.; Kosugi, S.; Ban, T.; Kohn, L.D.; Imura, H.; Mori, T. 1993: Chimeric studies of the extracellular domain of the rat thyrotropin (TSH) receptor: amino acids (268-304) in the TSH receptor are involved in ligand high affinity binding, but not in TSH receptor-specific signal transduction Endocrine Journal 40(3): 363-372
Voisin, M.-B.; Bitard, J.; Daburon, S.; Moreau, J.-F.ço.; Taupin, J.-L. 2002: Separate functions for the two modules of the membrane-proximal cytokine binding domain of glycoprotein 190, the leukemia inhibitory factor low affinity receptor, in ligand binding and receptor activation Journal of Biological Chemistry 277(16): 13682-13692
Dey, R.; Roychowdhury, P. 2002: Homology modelling of the ligand binding domain of mineralocorticoid receptor: close structural kinship with glucocorticoid receptor ligand binding domain and their similar binding mode with DOC (de-oxy corticosterone) Journal of Biomolecular Structure and Dynamics 20(1): 21-29
Nettles, K.W.; Bruning, J.B.; Gil, G.; O'Neill, E.E.; Nowak, J.; Guo, Y.; Hughs, A.; Kim, Y.; DeSombre, E.R.; Dilis, R.; Hanson, R.N.; Joachimiak, A.; Greene, G.L. 2007: Structural plasticity in the oestrogen receptor ligand-binding domain Embo Reports 8(6): 563-568
Kang, H. 2015: Effects of co-expression of liver X receptor β-ligand binding domain with its partner, retinoid X receptor α-ligand binding domain, on their solubility and biological activity in Escherichia coli Journal of Microbiology and Biotechnology 25(2): 247-254
Whitelaw, M.L.; Göttlicher, M.; Gustafsson, J.A.; Poellinger, L. 1993: Definition of a novel ligand binding domain of a nuclear bHlh receptor: co-localization of ligand and hsp90 binding activities within the regulable inactivation domain of the dioxin receptor The Embo Journal 12(11): 4169-4179
Whitelaw, M.L.; Göttlicher, M.; Gustafsson, J.A.; Poellinger, L. 1993: Definition of a novel ligand binding domain of a nuclear bHLH receptor: co-localization of ligand and hsp90 binding activities within the regulable inactivation domain of the dioxin receptor EMBO Journal 12(11): 4169-4179
Sumbayev, V.V.; Bonefeld-Jørgensen, E.C.; Wind, T.; Andreasen, P.A. 2005: A novel pesticide-induced conformational state of the oestrogen receptor ligand-binding domain, detected by conformation-specific peptide binding Febs Letters 579(2): 541-548
Smart, J.E.; Familletti, P.C.; Weber, D.V.; Keeney, R.F.; Bailon, P. 1990: Purification of the IL-2 receptor (TAC) by ligand-affinity chromatography and utilization of the immobilized receptor for receptor-affinity chromatography (RAC) purification of IL-2, mutant IL-2, and IL-2 fusion proteins J. Invest. Dermatol 94(6): 158S-163S
Smart, J.E.; Familletti, P.C.; Weber, D.V.; Keeney, R.F.; Bailon, P. 1990: Purification of the IL-2 receptor (TAC) by ligand-affinity chromatography and utilization of the immobilized receptor for receptor-affinity chromatography (RAC) purification of IL-2, mutant IL-2, and IL-2 fusion proteins Journal of Investigative Dermatology 94(6): 158s-163s
Møller, L.B.; Pöllänen, J.; Rønne, E.; Pedersen, N.; Blasi, F. 1993: N-linked glycosylation of the ligand-binding domain of the human urokinase receptor contributes to the affinity for its ligand Journal of Biological Chemistry 268(15): 11152-11159
Pelczar, H.; Albagli, O.; Chotteau-Lelievre, A.; Damour, I.; de Launoit, Y. 1997: A conditional version of the Ets transcription factor Erm by fusion to the ligand binding domain of the oestrogen receptor Biochemical and Biophysical Research Communications 239(1): 252-256
Byford, M.F.; Higman, J.R.; Darbre, P.D.; Sauer, M.J. 2001: Parabens bind directly to recombinant human oestrogen receptor ligand binding domain Biochemical Society Transactions 29(1): A41